tiprankstipranks
Trending News
More News >
Fate Therapeutics (FATE)
NASDAQ:FATE
US Market

Fate Therapeutics (FATE) Income Statement

Compare
1,263 Followers

Fate Therapeutics Income Statement

Last quarter (Q4 2025), Fate Therapeutics's total revenue was $1.37M, a decrease of -26.40% from the same quarter last year. In Q4, Fate Therapeutics's net income was $-32.37M. See Fate Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 6.65M$ 13.63M$ 63.53M$ 96.30M$ 55.85M
Gross Profit
$ -6.25M$ 13.63M$ -93.65M$ 82.54M$ 50.00M
Operating Expenses
$ 141.45M$ 223.91M$ 96.86M$ 390.93M$ 266.99M
Depreciation and Amortization
$ 9.29M$ 18.96M$ 18.28M$ 13.76M$ 5.85M
EBITDA
$ -127.02M$ -176.58M$ -172.23M$ -294.63M$ -211.14M
Operating Income
$ -147.70M$ -210.28M$ -190.51M$ -308.39M$ -216.99M
Other Income/Expenses
$ 11.39M$ 24.01M$ 29.58M$ 26.66M$ 4.84M
Pretax Income
$ -136.31M$ -186.26M$ -160.93M$ -281.72M$ -212.15M
Net Income
$ -136.31M$ -186.26M$ -160.93M$ -281.72M$ -212.15M
Per Share Metrics
Basic EPS
$ -1.15$ -1.64$ -1.64$ -2.91$ -2.24
Diluted EPS
$ -1.15$ -1.64$ -1.64$ -2.91$ -2.24
Weighted Average Shares Outstanding
118.79M 113.69M 98.41M 96.83M 94.75M
Weighted Average Shares Outstanding (Diluted)
118.79M 113.69M 98.41M 96.83M 94.75M
Currency in USD

Fate Therapeutics Earnings and Revenue History